Haid International Holdings Limited: Hong Kong Main Board IPO Application Lapsed, Second-Largest Aquafeed Supplier in Asia Excluding East Asia
NewTimeSpace News: According to HKEX disclosures, the Hong Kong Main Board listing application submitted by Haid International Holdings Limited on 12 January 2026 has recently lapsed upon expiry of the six-month validity period. JPMorgan, CICC and GF Securities acted as joint sponsors at the time of filing. The Company is a technology-driven global agricultural enterprise, ranking as the second-largest aquafeed supplier in Asia excluding East Asia by output volume in 2024.
NewTimeSpace News: Information published on the HKEX website shows that the Hong Kong Main Board listing application submitted by Haid International Holdings Limited on 12 January 2026 has recently lapsed after the six-month validity period expired. JPMorgan, CICC and GF Securities served as joint sponsors upon submission.
Haid International is a technology-driven global agricultural enterprise anchored in feed business, delivering comprehensive integrated solutions covering the full value chain of livestock farming. Its core markets span Asia excluding East Asia, Africa and Latin America. According to Frost & Sullivan data, measured by output volume in 2024, the Company ranks as the second-largest aquafeed supplier in Asia excluding East Asia with aquafeed output reaching 1 million tonnes. It is also Vietnam’s third-largest feed supplier with total feed output of 1.7 million tonnes.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
- MODERN LAND (01107.HK): Receives HKEX Resumption Guidance, Required to Publish Outstanding Results & Demonstrate Effective Internal Controls; Shares Remain Suspended
- LEADS BIOLABS-B (09887.HK): Six Research Abstracts Accepted for ESMO Congress 2026, Including Two Proffered Paper Presentations and LBA Eligibility
